Suppr超能文献

Th9 细胞因子抑制宫颈癌的进展和免疫逃逸。

Th9 cytokines curb cervical cancer progression and immune evasion.

机构信息

Division of Molecular Genetics & Biochemistry, ICMR-National Institute of Cancer Prevention and Research, Noida, India.

CSIR-Institute of Genomics and Integrative Biology, Delhi, India.

出版信息

Hum Immunol. 2019 Dec;80(12):1020-1025. doi: 10.1016/j.humimm.2019.09.009. Epub 2019 Sep 25.

Abstract

Cervical cancer is one of the most common cancers among women in developing countries. Persistent infection with high-risk human papillomavirus (HPV) is the major determinant for the development of cervical cancer. Role of newly discovered T helper 9 (Th9) cells in cervical cancer pathogenesis is yet unfolded. In this study, we observed a huge infiltration of PU.1 cells and overrepresentation of IL-9R in tissue biopsy specimens of CIN patients in cervical cancer cases. Treatment with Th9 signatory cytokines, IL-9 and IL-21, suppressed proliferation, enhanced apoptosis and stimulated the expression of MHC I and e-cadherin on HeLa cell lines. Th9 thus seems enhance antitumor immune response through T cell cytotoxicity and play crucial role in a controlling malignant cell transformation. Therefore, this study helps in firmer understanding of relevance of Th9 in cervical cancer immunity.

摘要

宫颈癌是发展中国家女性最常见的癌症之一。高危型人乳头瘤病毒(HPV)的持续感染是宫颈癌发展的主要决定因素。新发现的辅助性 T 细胞 9(Th9)细胞在宫颈癌发病机制中的作用尚不清楚。在这项研究中,我们观察到在宫颈癌病例的 CIN 患者的组织活检标本中,PU.1 细胞大量浸润和 IL-9R 过表达。Th9 签名细胞因子 IL-9 和 IL-21 的治疗抑制了 HeLa 细胞系的增殖,增强了细胞凋亡,并刺激了 MHC I 和 E-钙粘蛋白的表达。因此,Th9 通过 T 细胞细胞毒性增强抗肿瘤免疫反应,并在控制恶性细胞转化中发挥关键作用。因此,这项研究有助于更深入地了解 Th9 在宫颈癌免疫中的相关性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验